Table of Contents

1 Study Coverage

• 1.1 Biosurgery Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Biosurgery Market Size Growth Rate by Product
  • 1.4.2 Surgical Sealants
  • 1.4.3 Hemostatic Agents
  • 1.4.4 Adhesion Barriers
  • 1.4.5 Bone Graft Substitutes
  • 1.4.6 Staple Line Reinforcement Agents
• 1.5 Market by End User
  • 1.5.1 Global Biosurgery Market Size Growth Rate by End User
  • 1.5.2 Neurological Surgeries
  • 1.5.3 Cardiovascular Surgeries
  • 1.5.4 General Surgeries
  • 1.5.5 Orthopedic Surgeries
  • 1.5.6 Thoracic Surgeries
  • 1.5.7 Gynecology Surgeries
  • 1.5.8 Urology Surgeries
  • 1.5.9 Reconstructive Surgeries
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Biosurgery Market Size
  • 2.1.1 Global Biosurgery Revenue 2014-2025
  • 2.1.2 Global Biosurgery Sales 2014-2025
• 2.2 Biosurgery Growth Rate by Regions
  • 2.2.1 Global Biosurgery Sales by Regions
  • 2.2.2 Global Biosurgery Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Biosurgery Sales by Manufacturers
  • 3.1.1 Biosurgery Sales by Manufacturers
  • 3.1.2 Biosurgery Sales Market Share by Manufacturers
  • 3.1.3 Global Biosurgery Market Concentration Ratio (CR5 and HHI)
• 3.2 Biosurgery Revenue by Manufacturers
  • 3.2.1 Biosurgery Revenue by Manufacturers (2014-2019)
  • 3.2.2 Biosurgery Revenue Share by Manufacturers (2014-2019)
• 3.3 Biosurgery Price by Manufacturers
• 3.4 Biosurgery Manufacturing Base Distribution, Product Types
  • 3.4.1 Biosurgery Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Biosurgery Product Type
  • 3.4.3 Date of International Manufacturers Enter into Biosurgery Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Biosurgery Sales by Product
• 4.2 Global Biosurgery Revenue by Product
• 4.3 Biosurgery Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Biosurgery Breakdown Data by End User

6 North America

• 6.1 North America Biosurgery by Countries
  • 6.1.1 North America Biosurgery Sales by Countries
  • 6.1.2 North America Biosurgery Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Biosurgery by Product
• 6.3 North America Biosurgery by End User

7 Europe

• 7.1 Europe Biosurgery by Countries
  • 7.1.1 Europe Biosurgery Sales by Countries
  • 7.1.2 Europe Biosurgery Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Biosurgery by Product
• 7.3 Europe Biosurgery by End User

8 Asia Pacific

• 8.1 Asia Pacific Biosurgery by Countries
  • 8.1.1 Asia Pacific Biosurgery Sales by Countries
  • 8.1.2 Asia Pacific Biosurgery Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Biosurgery by Product
• 8.3 Asia Pacific Biosurgery by End User

9 Central & South America

• 9.1 Central & South America Biosurgery by Countries
  • 9.1.1 Central & South America Biosurgery Sales by Countries
  • 9.1.2 Central & South America Biosurgery Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Biosurgery by Product
• 9.3 Central & South America Biosurgery by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Biosurgery by Countries
  • 10.1.1 Middle East and Africa Biosurgery Sales by Countries
  • 10.1.2 Middle East and Africa Biosurgery Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Biosurgery by Product
• 10.3 Middle East and Africa Biosurgery by End User

11 Company Profiles

• 11.1 Baxter International
  • 11.1.1 Baxter International Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Baxter International Biosurgery Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Baxter International Biosurgery Products Offered
  • 11.1.5 Baxter International Recent Development
• 11.2 C.R. Bard
  • 11.2.1 C.R. Bard Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 C.R. Bard Biosurgery Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 C.R. Bard Biosurgery Products Offered
  • 11.2.5 C.R. Bard Recent Development
• 11.3 Johnson & Johnson
  • 11.3.1 Johnson & Johnson Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Johnson & Johnson Biosurgery Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Johnson & Johnson Biosurgery Products Offered
  • 11.3.5 Johnson & Johnson Recent Development
• 11.4 Covidien
  • 11.4.1 Covidien Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Covidien Biosurgery Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Covidien Biosurgery Products Offered
  • 11.4.5 Covidien Recent Development
• 11.5 Getinge Group
  • 11.5.1 Getinge Group Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Getinge Group Biosurgery Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Getinge Group Biosurgery Products Offered
  • 11.5.5 Getinge Group Recent Development
• 11.6 B. Braun Melsungen AG
  • 11.6.1 B. Braun Melsungen AG Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 B. Braun Melsungen AG Biosurgery Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 B. Braun Melsungen AG Biosurgery Products Offered
  • 11.6.5 B. Braun Melsungen AG Recent Development
• 11.7 Cryolife
  • 11.7.1 Cryolife Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Cryolife Biosurgery Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Cryolife Biosurgery Products Offered
  • 11.7.5 Cryolife Recent Development
• 11.8 Stryker Corporation
  • 11.8.1 Stryker Corporation Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Stryker Corporation Biosurgery Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Stryker Corporation Biosurgery Products Offered
  • 11.8.5 Stryker Corporation Recent Development
• 11.9 Hemostasis
  • 11.9.1 Hemostasis Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Hemostasis Biosurgery Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Hemostasis Biosurgery Products Offered
  • 11.9.5 Hemostasis Recent Development
• 11.10 Sanofi
  • 11.10.1 Sanofi Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Sanofi Biosurgery Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Sanofi Biosurgery Products Offered
  • 11.10.5 Sanofi Recent Development

12 Future Forecast

• 12.1 Biosurgery Market Forecast by Regions
  • 12.1.1 Global Biosurgery Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Biosurgery Revenue Forecast by Regions 2019-2025
• 12.2 Biosurgery Market Forecast by Product
  • 12.2.1 Global Biosurgery Sales Forecast by Product 2019-2025
  • 12.2.2 Global Biosurgery Revenue Forecast by Product 2019-2025
• 12.3 Biosurgery Market Forecast by End User
• 12.4 North America Biosurgery Forecast
• 12.5 Europe Biosurgery Forecast
• 12.6 Asia Pacific Biosurgery Forecast
• 12.7 Central & South America Biosurgery Forecast
• 12.8 Middle East and Africa Biosurgery Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Biosurgery Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Biosurgery market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Biosurgery market based on company, product type, end user and key regions.

This report studies the global market size of Biosurgery in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biosurgery in these regions.
This research report categorizes the global Biosurgery market by top players/brands, region, type and end user. This report also studies the global Biosurgery market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Baxter International
C.R. Bard
Johnson & Johnson
Covidien
Getinge Group
B. Braun Melsungen AG
Cryolife
Stryker Corporation
Hemostasis
Sanofi

Market size by Product
Surgical Sealants
Hemostatic Agents
Adhesion Barriers
Bone Graft Substitutes
Staple Line Reinforcement Agents
Market size by End User
Neurological Surgeries
Cardiovascular Surgeries
General Surgeries
Orthopedic Surgeries
Thoracic Surgeries
Gynecology Surgeries
Urology Surgeries
Reconstructive Surgeries

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Biosurgery market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Biosurgery market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Biosurgery companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Biosurgery submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Biosurgery are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biosurgery market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.